Search

Author/Creator Etienne, P.L.

1. 2095 Survival benefit, safety, and prognostic factors for outcome with Regorafenib (RE) in patients (pts) with pretreated metastatic colorectal cancer (mCRC). Main analyses of the REBECCA study. (September 2015)

Authors:
Fontaniere, C. De La Fouchardiere; Paule, B.; Burtin, P; Wallet, J.; Tougeron, D.; Dourthe, L.M.; Etienne, P.L.; Mineur, L.; Becuwe, C.; Maes, P.; Dauba, J.; Michel, P.; Wendling, J.L.; Linot, B.; Hollebecque, A.; Clisant, S.; Morere, J.F.; Andre, T.; Phelip, J.M.; Adenis, A.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S360
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS). (April 2019)

Authors:
Adenis, A.; Bennouna, J.; Etienne, P.L.; Bogart, E.; Francois, E.; Galais, M.P.; Ben Abdelghani, M.; Michel, P.; Metges, J.P.; Dahan, L.; Conroy, T.; Ghiringhelli, F.; Drouillard, A.; El Hajbi, F.; Samalin, E.; Hiret, S.; Delaine-Clisant, S.; Mariette, C.; Penel, N.; Piessen, G.
Journal:
European journal of cancer
Issue:
Volume 111(2019)
Page Start:
12
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial. (November 2018)

Authors:
Dahan, L.; Auby, D.; Khemissa, F.; Ghiringhelli, F.; Nguyen, S.; Bedjaoui, A.; Terrebonne, E.; Thaury, J.; Baconnier, M.; Bachet, J.B.; Lucidarme, O.; Levache, C.B.; Barbier, E.; Raoul, J.L.; Lecomte, T.; Desauw, C.; Brocard, F.; Pernot, S.; Breysacher, G.; Lagasse, J.P.
Journal:
European journal of cancer
Issue:
Volume 104(2018)
Page Start:
108
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search